메뉴 건너뛰기




Volumn 177, Issue 2, 2014, Pages 423-428

Macitentan treatment retards the progression of established pulmonary arterial hypertension in an animal model

Author keywords

ECG; Echocardiogram; Macitentan; Monocrotaline; Pulmonary arterial hypertension; Pulmonary hypertension

Indexed keywords

ENDOTHELIN RECEPTOR ANTAGONIST; MACITENTAN; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

EID: 84914097300     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.09.005     Document Type: Article
Times cited : (28)

References (27)
  • 1
    • 70049112901 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
    • N. Galie, M.M. Hoeper, M. Humbert, A. Torbicki, J.L. Vachiery, and J.A. Barbera Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 20 Oct 2009 2493 2537
    • (2009) Eur Heart J , vol.30 , Issue.20 , pp. 2493-2537
    • Galie, N.1    Hoeper, M.M.2    Humbert, M.3    Torbicki, A.4    Vachiery, J.L.5    Barbera, J.A.6
  • 2
    • 45249119855 scopus 로고    scopus 로고
    • Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): A double-blind, randomised controlled trial
    • N. Galie, L. Rubin, M. Hoeper, P. Jansa, H. Al-Hiti, and G. Meyer Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial Lancet 371 9630 2008 2093 2100
    • (2008) Lancet , vol.371 , Issue.9630 , pp. 2093-2100
    • Galie, N.1    Rubin, L.2    Hoeper, M.3    Jansa, P.4    Al-Hiti, H.5    Meyer, G.6
  • 3
    • 0346492721 scopus 로고    scopus 로고
    • The endothelin system in pulmonary arterial hypertension
    • N. Galie, A. Manes, and A. Branzi The endothelin system in pulmonary arterial hypertension Cardiovasc Res 61 2 2004 227 237
    • (2004) Cardiovasc Res , vol.61 , Issue.2 , pp. 227-237
    • Galie, N.1    Manes, A.2    Branzi, A.3
  • 4
    • 13844280943 scopus 로고    scopus 로고
    • Survival with first-line bosentan in patients with primary pulmonary hypertension
    • V.V. McLaughlin, O. Sitbon, D.B. Badesch, R.J. Barst, C. Black, and N. Galie Survival with first-line bosentan in patients with primary pulmonary hypertension Eur Respir J 25 2 Feb 2005 244 249
    • (2005) Eur Respir J , vol.25 , Issue.2 , pp. 244-249
    • McLaughlin, V.V.1    Sitbon, O.2    Badesch, D.B.3    Barst, R.J.4    Black, C.5    Galie, N.6
  • 6
    • 57349133022 scopus 로고    scopus 로고
    • Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist
    • M. Iglarz, C. Binkert, K. Morrison, W. Fischli, J. Gatfield, and A. Treiber Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist J Pharmacol Exp Ther 327 3 Dec 2008 736 745
    • (2008) J Pharmacol Exp Ther , vol.327 , Issue.3 , pp. 736-745
    • Iglarz, M.1    Binkert, C.2    Morrison, K.3    Fischli, W.4    Gatfield, J.5    Treiber, A.6
  • 8
    • 0014061764 scopus 로고
    • Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds
    • J.M. Kay, P. Harris, and D. Heath Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds Thorax 22 2 Mar 1967 176 179
    • (1967) Thorax , vol.22 , Issue.2 , pp. 176-179
    • Kay, J.M.1    Harris, P.2    Heath, D.3
  • 9
    • 0024320160 scopus 로고
    • Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats
    • D.W. Wilson, H.J. Segall, L.C. Pan, and S.K. Dunston Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats Microvasc Res 38 1 Jul 1989 57 80
    • (1989) Microvasc Res , vol.38 , Issue.1 , pp. 57-80
    • Wilson, D.W.1    Segall, H.J.2    Pan, L.C.3    Dunston, S.K.4
  • 10
    • 77955492061 scopus 로고    scopus 로고
    • A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model
    • J.W. Koskenvuo, R. Mirsky, Y. Zhang, F.S. Angeli, S. Jahn, and T.P. Alastalo A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model Int J Cardiovasc Imaging 26 5 Jun 2010 509 518
    • (2010) Int J Cardiovasc Imaging , vol.26 , Issue.5 , pp. 509-518
    • Koskenvuo, J.W.1    Mirsky, R.2    Zhang, Y.3    Angeli, F.S.4    Jahn, S.5    Alastalo, T.P.6
  • 11
    • 77956713444 scopus 로고    scopus 로고
    • Validation of high-resolution echocardiography and magnetic resonance imaging vs high-fidelity catheterization in experimental pulmonary hypertension
    • D. Urboniene, I. Haber, Y.H. Fang, T. Thenappan, and S.L. Archer Validation of high-resolution echocardiography and magnetic resonance imaging vs high-fidelity catheterization in experimental pulmonary hypertension Am J Physiol Lung Cell Mol Physiol 299 3 Sep 2010 L401 L412
    • (2010) Am J Physiol Lung Cell Mol Physiol , vol.299 , Issue.3 , pp. 401-L412
    • Urboniene, D.1    Haber, I.2    Fang, Y.H.3    Thenappan, T.4    Archer, S.L.5
  • 12
    • 33744907723 scopus 로고    scopus 로고
    • Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats
    • M. Clozel, P. Hess, M. Rey, M. Iglarz, C. Binkert, and C. Qiu Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats Exp Biol Med (Maywood) 231 6 Jun 2006 967 973
    • (2006) Exp Biol Med (Maywood) , vol.231 , Issue.6 , pp. 967-973
    • Clozel, M.1    Hess, P.2    Rey, M.3    Iglarz, M.4    Binkert, C.5    Qiu, C.6
  • 13
    • 80555144097 scopus 로고    scopus 로고
    • VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension
    • S.A. Hamidi, R.Z. Lin, A.M. Szema, S. Lyubsky, Y.P. Jiang, and S.I. Said VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension Respir Res 12 2011 141
    • (2011) Respir Res , vol.12 , pp. 141
    • Hamidi, S.A.1    Lin, R.Z.2    Szema, A.M.3    Lyubsky, S.4    Jiang, Y.P.5    Said, S.I.6
  • 14
    • 35348869290 scopus 로고    scopus 로고
    • Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: The rapamcyin-atorvastatin-simvastatin study
    • M.S. McMurtry, S. Bonnet, E.D. Michelakis, A. Haromy, and S.L. Archer Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study Am J Physiol Lung Cell Mol Physiol 293 4 Oct 2007 L933 L940
    • (2007) Am J Physiol Lung Cell Mol Physiol , vol.293 , Issue.4 , pp. 933-L940
    • McMurtry, M.S.1    Bonnet, S.2    Michelakis, E.D.3    Haromy, A.4    Archer, S.L.5
  • 15
    • 67650069940 scopus 로고    scopus 로고
    • Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension
    • K.T. Mouchaers, I. Schalij, A.M. Versteilen, A.M. Hadi, G.P. van Nieuw Amerongen, and V.W. van Hinsbergh Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension Am J Physiol Heart Circ Physiol 297 1 Jul 2009 H200 H207
    • (2009) Am J Physiol Heart Circ Physiol , vol.297 , Issue.1 , pp. 200-H207
    • Mouchaers, K.T.1    Schalij, I.2    Versteilen, A.M.3    Hadi, A.M.4    Van Nieuw Amerongen, G.P.5    Van Hinsbergh, V.W.6
  • 16
    • 0030862759 scopus 로고    scopus 로고
    • Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats
    • N.S. Hill, R.R. Warburton, L. Pietras, and J.R. Klinger Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats J Appl Physiol 83 4 Oct 1997 1209 1215
    • (1997) J Appl Physiol , vol.83 , Issue.4 , pp. 1209-1215
    • Hill, N.S.1    Warburton, R.R.2    Pietras, L.3    Klinger, J.R.4
  • 17
    • 0029785906 scopus 로고    scopus 로고
    • Telemetry monitoring of pulmonary arterial pressure in freely moving rats
    • P. Hess, M. Clozel, and J.P. Clozel Telemetry monitoring of pulmonary arterial pressure in freely moving rats J Appl Physiol 81 2 Aug 1996 1027 1032
    • (1996) J Appl Physiol , vol.81 , Issue.2 , pp. 1027-1032
    • Hess, P.1    Clozel, M.2    Clozel, J.P.3
  • 18
    • 0033027294 scopus 로고    scopus 로고
    • The ET(A)-receptor antagonist LU 135252 prevents the progression of established pulmonary hypertension induced by monocrotaline in rats
    • J. Dupuis, and S. Prie The ET(A)-receptor antagonist LU 135252 prevents the progression of established pulmonary hypertension induced by monocrotaline in rats J Cardiovasc Pharmacol Ther 4 1 Jan 1999 33 39
    • (1999) J Cardiovasc Pharmacol Ther , vol.4 , Issue.1 , pp. 33-39
    • Dupuis, J.1    Prie, S.2
  • 19
    • 14444283145 scopus 로고    scopus 로고
    • The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats
    • S. Prie, T.K. Leung, P. Cernacek, J.W. Ryan, and J. Dupuis The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats J Pharmacol Exp Ther 282 3 Sep 1997 1312 1318
    • (1997) J Pharmacol Exp Ther , vol.282 , Issue.3 , pp. 1312-1318
    • Prie, S.1    Leung, T.K.2    Cernacek, P.3    Ryan, J.W.4    Dupuis, J.5
  • 20
    • 84865313805 scopus 로고    scopus 로고
    • Caveolin-1 expression during the progression of pulmonary hypertension
    • J. Huang, J.H. Wolk, M.H. Gewitz, and R. Mathew Caveolin-1 expression during the progression of pulmonary hypertension Exp Biol Med (Maywood) 237 8 2012 956 965
    • (2012) Exp Biol Med (Maywood) , vol.237 , Issue.8 , pp. 956-965
    • Huang, J.1    Wolk, J.H.2    Gewitz, M.H.3    Mathew, R.4
  • 21
    • 0032474287 scopus 로고    scopus 로고
    • EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension
    • S. Prie, D.J. Stewart, and J. Dupuis EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension Circulation 97 21 1998 2169 2174
    • (1998) Circulation , vol.97 , Issue.21 , pp. 2169-2174
    • Prie, S.1    Stewart, D.J.2    Dupuis, J.3
  • 22
    • 78149314671 scopus 로고    scopus 로고
    • Gene expression of endothelin-1 and endothelin receptor a on monocrotaline-induced pulmonary hypertension in rats after bosentan treatment
    • K.A. Lim, K.C. Kim, M.S. Cho, B.E. Lee, H.S. Kim, and Y.M. Hong Gene expression of endothelin-1 and endothelin receptor a on monocrotaline-induced pulmonary hypertension in rats after bosentan treatment Korean Circ J 40 9 Sep 2010 459 464
    • (2010) Korean Circ J , vol.40 , Issue.9 , pp. 459-464
    • Lim, K.A.1    Kim, K.C.2    Cho, M.S.3    Lee, B.E.4    Kim, H.S.5    Hong, Y.M.6
  • 23
    • 79958044088 scopus 로고    scopus 로고
    • Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy
    • D. Benoist, R. Stones, M. Drinkhill, O. Bernus, and E. White Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy Am J Physiol Heart Circ Physiol 300 6 Mar 11 2011 H2230 H2237
    • (2011) Am J Physiol Heart Circ Physiol , vol.300 , Issue.6 , pp. 2230-H2237
    • Benoist, D.1    Stones, R.2    Drinkhill, M.3    Bernus, O.4    White, E.5
  • 25
    • 84880923973 scopus 로고    scopus 로고
    • QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension
    • J.D. Rich, T. Thenappan, B. Freed, A.R. Patel, R.A. Thisted, and R. Childers QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension Int J Cardiol 167 3 2013 669 676
    • (2013) Int J Cardiol , vol.167 , Issue.3 , pp. 669-676
    • Rich, J.D.1    Thenappan, T.2    Freed, B.3    Patel, A.R.4    Thisted, R.A.5    Childers, R.6
  • 26
    • 84863338009 scopus 로고    scopus 로고
    • Spontaneous ventricular fibrillation in right ventricular failure secondary to chronic pulmonary hypertension
    • S. Umar, J.H. Lee, E. de Lange, A. Iorga, R. Partow-Navid, and A. Bapat Spontaneous ventricular fibrillation in right ventricular failure secondary to chronic pulmonary hypertension Circ Arrhythm Electrophysiol 5 1 Feb 2012 181 190
    • (2012) Circ Arrhythm Electrophysiol , vol.5 , Issue.1 , pp. 181-190
    • Umar, S.1    Lee, J.H.2    De Lange, E.3    Iorga, A.4    Partow-Navid, R.5    Bapat, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.